{{Rsnum
|rsid=4769874
|Gene=ALOX5AP
|Chromosome=13
|position=30752304
|Orientation=plus
|GMAF=0.05051
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ALOX5AP
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 5.3 | 94.7
| HCB | 0.7 | 3.7 | 95.6
| JPT | 0.0 | 2.7 | 97.3
| YRI | 0.0 | 22.4 | 77.6
| ASW | 1.8 | 24.6 | 73.7
| CHB | 0.7 | 3.7 | 95.6
| CHD | 0.0 | 3.7 | 96.3
| GIH | 0.0 | 23.8 | 76.2
| LWK | 0.0 | 21.8 | 78.2
| MEX | 0.0 | 1.7 | 98.3
| MKK | 1.9 | 18.6 | 79.5
| TSI | 1.0 | 16.7 | 82.4
| HapMapRevision=28
}}

[[rs4769874]], also known as SG13S89, is an [[ALOX5AP]] gene SNP that has been defined as part of a haplotype potentially associated with risk for [[myocardial infarction]] or ischemic [[stroke]]. Details of this haplotype and several related studies are on the [[ALOX5AP]] page.

{{PMID Auto
|PMID=17387518
|Title=Association of ALOX5AP with ischemic stroke: a population-based case-control study.
}}

{{PMID Auto
|PMID=19130089
|Title=Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.
|OA=1
}}

{{PMID Auto
|PMID=20592751
|Title=Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study.
|OA=1
}}

{{PMID Auto
|PMID=24368493
|Title=Interaction between ALOX5AP and CYP3A5 gene variants significantly increases the risk for cerebral infarctions in Chinese
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}